Unless you are from another planet, you’ve heard all about the new weight loss medications taking the world by storm. These ...

GLP-1RA use, but not SGLT2i or pioglitazone use, was associated with a statistically significant lower risk for dementia and cognitive impairment.

GLP-1 weight-loss drugs are reshaping dairy demand by curbing cravings for processed, fatty, and sugary products, fueling a ...

In patients with T2D, GLP-1s don’t increase the risk for acute pancreatitis, mitigate the risk for complications in those who ...

Stat reports on the unlikely collaboration between telehealth providers and manufacturers. Other health industry news is on the rising popularity of fractional chief financial officers, and the ...